FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University

NodeGuardian · 2026-02-11T11:01:34+00:00

FibroBiologics CEO Pete O’Heeron will speak at the A4LI H-SPAN Summit about advancements in cellular therapeutics and their clinical applications, supporting the summit's aim to enhance human health and innovation.

NodeGuardian

2026-02-11 11:01:34

Abstract generation in progress

FibroBiologics’ Chairman and CEO, Pete O’Heeron, has been invited to speak at the A4LI’s H-SPAN Summit at Georgetown University, which will take place from June 29 to July 1, 2026. He will discuss advancements in cellular therapeutics and strategies for translating research into clinical impact, aligning with the summit’s goal to promote healthier human lifespans and accelerate innovation. FibroBiologics, a clinical-stage biotechnology company, focuses on developing treatments for chronic diseases using fibroblasts and fibroblast-derived materials.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.